Liu F T, Hsu D K, Zuberi R I, Kuwabara I, Chi E Y, Henderson W R
Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, California 92037, USA.
Am J Pathol. 1995 Oct;147(4):1016-28.
A family of beta-galactoside-binding animal lectins has recently been designated as galectins. One member of this family, galectin-3, has been known as epsilon BP for its IgE-binding activity and as Mac-2, a macrophage surface antigen, CBP35, CBP30, L-29, and L-34. Although much information has accumulated on the expression of this lectin in murine macrophages and human monocytic cell lines, little is known about the expression and function of this protein in normal human monocytes/macrophages. We now report that galectin-3 is expressed in normal human peripheral blood monocytes and its level increases dramatically as human monocytes differentiate into macrophages upon culturing in vitro. Immunoblot analysis showed that there was a 5-fold increase in the level of galectin-3 after 1 day of culture and greater than a 12-fold increase after 5 days. Immunocytochemical analysis confirmed this progressive increase of galectin-3 expression in cultured monocytes. Immunogold cytochemistry/electron microscopy analysis revealed that galectin-3 was expressed on the surface of human monocytes and that the level of cell surface galectin-3 increased progressively as these cells differentiated into macrophages. The level of galectin-3 in human monocytes/macrophages was modulated by stimuli such as lipopolysaccharide and interferon-gamma, and galectin-3 was secreted when monocytes were stimulated by calcium ionophore A23187 Soluble galectin-3 caused superoxide release from human monocytes; this activity was dependent on the lectin property of galectin-3, as it was inhibitable by lactose. Thus, galectin-3 may modulate the function of this cell type in an autocrine or paracrine fashion through binding to cell surface glycoconjugates.
一类β-半乳糖苷结合动物凝集素最近被命名为半乳糖凝集素。该家族的一个成员,半乳糖凝集素-3,因其与IgE结合的活性而被称为εBP,也被称为Mac-2,一种巨噬细胞表面抗原、CBP35、CBP30、L-29和L-34。尽管关于这种凝集素在小鼠巨噬细胞和人单核细胞系中的表达已经积累了很多信息,但对于该蛋白在正常人单核细胞/巨噬细胞中的表达和功能却知之甚少。我们现在报告,半乳糖凝集素-3在正常人外周血单核细胞中表达,并且当人单核细胞在体外培养分化为巨噬细胞时,其水平会显著增加。免疫印迹分析表明,培养1天后半乳糖凝集素-3的水平增加了5倍,培养5天后增加超过12倍。免疫细胞化学分析证实了培养的单核细胞中半乳糖凝集素-3表达的这种逐渐增加。免疫金细胞化学/电子显微镜分析显示,半乳糖凝集素-3在人单核细胞表面表达,并且随着这些细胞分化为巨噬细胞,细胞表面半乳糖凝集素-3的水平逐渐增加。人单核细胞/巨噬细胞中半乳糖凝集素-3的水平受到脂多糖和干扰素-γ等刺激的调节,当单核细胞受到钙离子载体A23187刺激时,半乳糖凝集素-3会分泌出来。可溶性半乳糖凝集素-3会导致人单核细胞释放超氧化物;这种活性依赖于半乳糖凝集素-3的凝集素特性,因为它可被乳糖抑制。因此,半乳糖凝集素-3可能通过与细胞表面糖缀合物结合,以自分泌或旁分泌方式调节这种细胞类型的功能。